Scientists have created a form of water which can zap hospital superbugs and speed up wound healing. Dermacyn – dubbed "miracle water" – is effective against infections ranging from MRSA to TB and has just been approved for sale in the UK.



A splash of Dermacyn can speed up the healing of wounds


A splash can also speed up the healing of wounds by increasing the flow of blood to the area.

Dan McFadden, of manufacturer Oculus, said: "People think it is too good to be true. Our challenge is to get beyond that disbelief. This is the real thing."

The liquid is a chemically-altered version of salty water which is full of negatively-charged particles.

These are capable of killing dangerous micro-organisms by punching holes in their cell walls.

While bacteria and viruses are quickly dispatched, human cells are left intact because they are packed too tightly together to be attacked.

The potion costs around £16 a bottle and has a shelf-life of two years, New Scientist magazine reported.

Dermacyn is recommended for external use only and so should not be drunk.

However, drinking it is not known to do any harm – and may even clear up bad breath, according to its makers.

In trials on diabetic patients, the water was more effective at clearing up hard-to-treat foot ulcers than existing treatments.

Ulcers that took 55 days to heal when treated with iodine and antibiotics took 43 days when Dermacyn was used instead.

Dr Cheryl Bongiovanni, who has used the product on more than 1,000 patients in Oregon, said: "When you spray it on, you see the treated tissue ‘pink up’ and go beefy, which is good because it means the oxygen supply has resumed."

Other tests have shown that small amounts can kill vast quantities of bacteria, viruses and fungi – including many that are unaffected by bleach.

Vulnerable germs include the hospital superbugs MRSA and clostridium difficile, food poisoning bacteria e.coli and salmonella, and the TB bug and HIV.

Kim Kelderman, an executive at Californiabased Oculus, said: "Disinfection is generally known as the important prerequisite for chronic wounds to heal.

"The challenge is to effectively reduce the bacterial load, while remaining harmless to the healthy tissue surrounding the wound.

"We developed a technology with a method of action similar to the body’s own process when killing bacteria, including resistant strains like MRSA. This is a breakthrough in wound treatment."

Dermacyn, which is available as a solution and a spray, is on sale in the U.S. and has been licensed for over-the-counter sale in the UK.

However, its manufacturers do not plan to start selling it here unless they receive large-scale orders for its use in the Health Service.

British experts yesterday welcomed the innovation.

Professor Andrew Boulton, who is investigating the solution’s wound healing effects at Manchester Royal Infirmary, said initial signs were "promising".

Mike Foster, of Help the Aged, added: "Chronic leg wounds are a significant cause of disability and distress for older people. They cost £1billion per year to treat.

"There is an urgent need to understand the biology of our repair systems so that we can improve treatments that will help to restore more people’s health and independence."

Via the Daily Mail